Intelligence · Clinical Development
Pipeline search results
Programs matching “Gilead Sciences” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 56 pipeline programs matching "Gilead Sciences" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
LDV/SOF
Gilead Sciences Ireland UC
Hepatitis C Virus
1 trial -
Placebo to match 10 mg, Placebo to match 5 mg
Gilead Sciences Pty Limited
Primary Biliary Cholangitis
1 trial -
SOF/VEL
Gilead Sciences Ireland UC
Hepatitis C Virus Infection
3 trials -
SOF/VEL/VOX
Gilead Sciences Ireland UC
Hepatitis C Virus Infection
1 trial -
Sacituzumab Govitecan-hziy
Gilead Sciences Ireland UC
Triple Negative Breast Cancer
1 trial -
Sofosbuvir
Gilead Sciences Ireland UC
Hepatitis C
2 trials -
Sofosbuvir
Gilead Sciences Ireland UC
Chronic HCV Infection
1 trial -
Tenofovir DF
Gilead Sciences Ireland UC
Chronic Hepatitis B
1 trial -
Andecaliximab
Gilead Sciences Ireland UC
Crohn's Disease
1 trial -
BSF 208075
Gilead Sciences Ireland UC
Pulmonary Hypertension
1 trial -
EDGE-Lung
Gilead Sciences Pty Limited
Advanced Non-Small Cell Lung Cancer
1 trial -
GS-4321 PLACEBO
Gilead Sciences Pty Limited
Chronic Hepatitis Delta.
1 trial -
GS-US-409-5704
Gilead Sciences Pty Limited
Ulcerative Colitis (UC)
1 trial -
GS-US-576-6220
Gilead Sciences Pty Limited
Non-small cell lung cancer
1 trial -
GS-US-699-7184-01
Gilead Sciences Pty Limited
Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
1 trial -
IMMU-132-06
Gilead Sciences Pty Limited
Locally Advanced/Metastatic Urothelial Cancer
1 trial -
Presatovir
Gilead Sciences Ireland UC
Respiratory Syncytial Virus
1 trial -
SOF
Gilead Sciences Ireland UC
HCV Infection
1 trial -
SOF
Gilead Sciences Ireland UC
Hepatitis C Virus Infection
1 trial -
Trodelvy 200 mg powder for concentrate for solution for infusion
Gilead Sciences Pty Limited
Metastatic Solid Tumors
1 trial -
VOX
Gilead Sciences Ireland UC
Hepatitis C Virus Infection
1 trial -
B/F/TAF
Gilead Sciences Ireland UC
HIV-1-infection
1 trial -
Evixapodlin
Gilead Sciences Ireland UC
Advanced Solid Tumors
1 trial -
GS-0272
Gilead Sciences Ireland UC
Rheumatoid Arthritis
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.